Valuation: Becton, Dickinson and Company

Market Cap 50.05B 44.7B 41.58B 37.82B 71.41B 4,844B 71.72B 500B 196B 2,470B 188B 184B 7,925B P/E 2026 *
35.4x
P/E 2027 * 19.7x
Enterprise Value 65.94B 58.89B 54.78B 49.83B 94.08B 6,381B 94.49B 659B 258B 3,253B 248B 242B 10,440B EV / Sales 2026 *
3.42x
EV / Sales 2027 * 3.24x
Free-Float
73.18%
Yield 2026 *
2.14%
Yield 2027 * 2.17%
1 day+0.55%
1 week+3.93%
Current month+2.65%
1 month+2.20%
3 months+21.81%
6 months+18.20%
Current year-5.32%
1 week 176.04
Extreme 176.04
187.45
1 month 175.2
Extreme 175.2
187.45
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
266.29
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 27/01/2020
Director of Finance/CFO 44 04/12/2025
Chief Tech/Sci/R&D Officer 56 03/12/2023
Director TitleAgeSince
Director/Board Member 75 23/09/2002
Director/Board Member 71 25/07/2010
Chairman 53 27/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
28/09/26 Sell

Executive/Senior Manager

-76 0.0000%
02/09/26 Tax

Chief Financial Officer

-190 0.0001%
26/08/26 Sell

Executive/Senior Manager

-165 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.55%+3.93%-2.82%-30.87% 50.05B
+1.13%+2.15%-25.29%+2.94% 172B
+0.83%+2.43%-8.31%+17.77% 113B
+0.13%+0.69%-25.09%+3.95% 106B
+2.34%+2.49%-47.36%-10.38% 75.31B
+0.78%+4.79%+3.10%+73.94% 61.8B
+0.12%+3.62%+12.66%+67.70% 52.93B
+0.95%-0.08%-17.61%+17.13% 40.81B
-0.36%-1.46%+23.55%+1.23% 31.74B
+1.45%+1.83% - - 31.81B
Average +0.79%+1.93%-9.69%+15.93% 73.64B
Weighted average by Cap. +0.86%+2.08%-15.31%+13.49%

Financials

2026 *2027 *
Net sales 19.28B 17.22B 16.02B 14.57B 27.5B 1,866B 27.62B 193B 75.52B 951B 72.39B 70.81B 3,052B 19.74B 17.63B 16.4B 14.92B 28.16B 1,910B 28.28B 197B 77.33B 974B 74.12B 72.5B 3,125B
Net income 1.44B 1.28B 1.19B 1.09B 2.05B 139B 2.06B 14.37B 5.63B 70.89B 5.39B 5.28B 227B 2.34B 2.09B 1.94B 1.77B 3.34B 226B 3.35B 23.39B 9.17B 115B 8.79B 8.59B 370B
Net Debt 15.88B 14.19B 13.2B 12B 22.66B 1,537B 22.76B 159B 62.24B 784B 59.65B 58.35B 2,515B 13.95B 12.46B 11.59B 10.54B 19.91B 1,350B 19.99B 140B 54.66B 688B 52.39B 51.25B 2,209B
Projected Income Statement - Annual - Becton, Dickinson and Company
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
09/10/26 US$183.75 +0.55% 1,615,714
08/10/26 US$182.75 +1.44% 1,523,705
07/10/26 US$180.16 -0.08% 1,922,325
06/10/26 US$180.30 -0.20% 2,053,267
05/10/26 US$180.67 +2.19% 1,644,968
Trader
Investor
Global
Quality
ESG MSCI
A
Ratings Surperformance© - Becton, Dickinson and Company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
183.75USD
Average target price
194.08USD
Spread / Average Target
+5.62%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Becton, Dickinson and Company